Adding Relatlimab to Nivolumab/Chemo Did Not Increase Toxicity
Hypofractionated Radiation Noninferior for Lymphedema Prevention in Early Breast Cancer
Perioperative Durvalumab With Neoadjuvant Chemo Boosts Survival in Cisplatin-Eligible MIBC
Perioperative Pembrolizumab Improves Survival in Early-Stage TNBC